openPR Logo
Press release

Tuberculosis Therapeutics Market Size - Forecasts to 2026

Tuberculosis Therapeutics Market

Tuberculosis Therapeutics Market

As per the research conducted by GME, the Tuberculosis Therapeutics Market will grow with a CAGR value of 6 percent by 2026. Due to increasing tuberculosis prevalence, growing government initiatives for tuberculosis knowledge & understanding, effective cooperation amongst educational & corporate players for innovative drug production, and soaring incidence of MDR and XDR cases in both developed & developing countries are catapulting the market's expansion.

Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Tuberculosis Therapeutics Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-tuberculosis-therapeutics-market-3134

By Disease Type (Active TB and Latent TB), By Therapy (First-Line and Second-Line), By Region (North America, Asia Pacific, CSA, Europe, and The Middle East and Africa); End-User, Landscape, Company Market Share Analysis, and Competitor Analysis
Key Market Insights
• The growing volume of drug inventions along with the increasing number of respiratory organ diseases are driving the market.
• Active tuberculosis (ATB) segment is likely to dominate the market due to a surge in the volume of DS and MDR TB cases.
• Due to the cost-intensive layout of MDR TB products, second-line therapy is presumed to lead in this market.
• Due to the growing understanding of tuberculosis and its effects on human health, North America holds a significant share of the tuberculosis therapeutic market.
• Lupin, Macleods Pharmaceuticals Ltd, Otsuka Pharmaceutical Co. Ltd, Johnson & Johnson (J&J) Services, Novartis AG, Sigma Pharmaceutical Pvt. Ltd., Aventis Pharmaceuticals Ltd., Hoffmann-La Roche Ltd., VersaPharm Inc., Sanofi Aventis, and Bayer among others, are the top players in the tuberculosis therapeutics market.

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-tuberculosis-therapeutics-market-3134

Disease Type Outlook (Revenue, USD Billion, 2021-2026)
• Active TB
• Latent TB

Therapy Outlook (Revenue, USD Billion, 2021-2026)
• First-Line
• Second-Line

Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA

Contact: Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com/
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php

B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India

Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tuberculosis Therapeutics Market Size - Forecasts to 2026 here

News-ID: 2285737 • Views: 348

More Releases from Global Market Estimates Research & Consultants

AI in Biopharmaceutical Development Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global AI in Biopharmaceutical Development Market is projected to grow at a CAGR of 40.2 % from 2022 to 2027. IBM Watson Health, Google (Alphabet Inc.), Concreto HealthAI, Nvidia Corporation, PathAI, Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Ai-biopharma S.A.S., and Microsoft Corporation among others, are some key players in the AI in Biopharmaceutical Development Market. Browse 153
Predictive Analytics in Retail Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Predictive Analytics in Retail Market is projected to grow at a CAGR of 23.5% from 2022 to 2027. The demand for real-time analytical methods to track and monitor consumer behavior and purchase history, especially on online platforms, is expected to drive the market for predictive analytics in the retail industry. Browse 153 Market Data Tables and
Global Data Fabric Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Data Fabric Market is projected to grow at a CAGR of 26.5% from 2022 to 2027. Data fabric's benefits such as facilitating self-service data usage and interaction, automating administration, safety, and privacy enabled by active semantics, as well as automating data engineering chores, and enhancing integration across heterogeneous cloud resources, are some factors favoring the market growth. Browse
Molecular Diagnostics Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Molecular Diagnostics Market is projected to grow from USD 23.41 billion in 2022 to USD 31.24 billion at a CAGR value of 5.8% from 2022 to 2027. The major drivers of the molecular diagnostics market are the growing incidence of infectious diseases and genetic disorders among the population, increasing investment in the adoption of molecular diagnostic

All 5 Releases


More Releases for Tuberculosis

World Tuberculosis Day - Tuberculosis, the invisible pandemic
Tuberculosis is a disease that, every year, kills as many as COVID-19 does. March 24, World Tuberculosis Day, marks the anniversary of a momentous occasion - the discovery of the bacterium which causes tuberculosis in 1882. More than a hundred years after its discovery, tuberculosis is still a global health crisis. It is the leading cause of death from a single infectious disease agent, killing close to as many people per
Tuberculosis Diagnosis and Treatment Market
The Global Tuberculosis diagnosis and treatment market is relied upon to develop at a CAGR of 2.3 % amid 2017-2022. An irresistible illness caused by the bacterium Mycobacterium tuberculosis (MTB) is known as Tuberculosis (TB). Tuberculosis by and large influences the lungs yet can likewise influence different parts of the body. Inert tuberculosis is the sort of TB which don't have indications. Around 10% of inert contaminations advance to dynamic
Global Tuberculosis Diagnostics Sales Market Report 2018
The Global Tuberculosis Diagnostics Sales Market Report 2018 is a professional and in-depth study on the current state of the Tuberculosis Diagnostics industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Tuberculosis Diagnostics Industry analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This
Tuberculosis Testing Market | Analysis & Trends 2020
Key players in the Global Tuberculosis (TB) Testing Market, according to a report by Transparency Market Research, are Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Hain Lifescience GmbH, Hologic Inc. QIAGEN, Abbott Laboratories, Alere Inc., Epistem plc, Cepheid, bioMérieux SA, Akonni Biosystems Inc., and Sanofi. Among them, the top players namely, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, and Hain Lifescience GmbH
Tuberculosis Testing Market to Increasing Tuberculosis Awareness and Control Pro …
A new Transparency Market Research report states that the global tuberculosis testing market stood at US$1.9 bn in 2013 and is predicted to reach US$2.6 bn by 2020. It is predicted to expand at a CAGR of 4.30% from 2014 to 2020. The title of the report is “Tuberculosis Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020.” As per the report, the rising acceptance
Tuberculosis: A Neglected Pandemic
The German Center for Research and Innovation (GCRI), in cooperation with the Max Planck Florida Institute, will host a discussion on the treatments and challenges of tuberculosis on Thursday, March 31, from 7:00 to 9:00 p.m. The event will take place at the German House New York (871 United Nations Plaza, First Avenue, btw. 48th & 49th Streets). Tuberculosis, along with HIV/AIDS, is one of today’s deadliest threats. Killing one